B-intervention	0	7	Partial
I-intervention	8	13	lower
I-intervention	14	22	axillary
I-intervention	23	33	dissection
O	34	37	for
B-eligibility	38	46	patients
I-eligibility	47	51	with
I-eligibility	52	62	clinically
I-eligibility	63	67	node
I-eligibility	67	68	-
I-eligibility	68	76	negative
I-eligibility	77	83	breast
I-eligibility	84	90	cancer
O	90	91	.

O	92	94	To
O	95	103	evaluate
O	104	119	retrospectively
O	120	123	the
O	124	132	outcomes
O	133	135	of
O	136	143	partial
O	144	149	lower
O	150	158	axillary
O	159	164	lymph
O	165	169	node
O	170	180	dissection
O	181	187	caudal
O	188	190	to
O	191	194	the
O	195	213	intercostobrachial
O	214	219	nerve
O	220	222	in
O	223	231	patients
O	232	236	with
O	237	247	clinically
O	248	252	node
O	252	253	-
O	253	261	negative
O	262	263	(
O	263	264	N
O	264	265	(
O	265	266	0
O	266	267	)
O	267	268	)
O	269	275	breast
O	276	282	cancer
O	282	283	.

O	284	291	Numbers
O	292	294	of
O	295	304	dissected
O	305	308	and
O	309	319	metastatic
O	320	325	nodes
O	325	326	,
O	327	334	overall
O	335	338	and
O	339	346	disease
O	346	347	-
O	347	351	free
O	353	361	survival
O	362	367	rates
O	367	368	,
O	369	382	postoperative
O	383	395	complication
O	396	401	rates
O	401	402	,
O	403	406	and
O	407	415	axillary
O	416	426	recurrence
O	427	431	were
O	432	440	compared
O	441	448	between
O	449	457	patients
O	458	461	who
O	462	471	underwent
O	472	478	breast
O	479	485	cancer
O	486	493	surgery
O	494	498	with
O	499	506	partial
O	507	515	axillary
O	516	520	node
O	521	531	dissection
O	532	533	(
O	533	534	n
O	535	536	=
B-intervention-participants	537	541	1043
O	541	542	)
O	543	546	and
B-control	547	557	historical
I-control	558	566	controls
O	567	570	who
O	571	580	underwent
O	581	593	conventional
O	594	604	dissection
O	605	606	(
O	606	607	n
O	608	609	=
B-control-participants	610	614	1084
O	614	615	)
O	615	616	.

O	617	620	The
B-outcome	622	623	5
I-outcome	623	624	-
I-outcome	624	628	year
I-outcome	629	636	overall
O	637	640	and
B-outcome	641	648	disease
I-outcome	648	649	-
I-outcome	649	653	free
I-outcome	654	662	survival
I-outcome	663	668	rates
O	669	673	were
B-iv-bin-percent	674	676	95
I-iv-bin-percent	676	677	.
I-iv-bin-percent	677	678	6
I-iv-bin-percent	678	679	%
O	680	683	and
B-cv-bin-percent	684	686	89
I-cv-bin-percent	686	687	.
I-cv-bin-percent	687	688	7
I-cv-bin-percent	688	689	%
O	689	690	,
O	691	694	and
B-iv-bin-percent	695	697	94
I-iv-bin-percent	697	698	.
I-iv-bin-percent	698	699	9
I-iv-bin-percent	699	700	%
O	701	704	and
B-cv-bin-percent	705	707	88
I-cv-bin-percent	707	708	.
I-cv-bin-percent	708	709	4
I-cv-bin-percent	709	710	%
O	710	711	,
O	712	724	respectively
O	724	725	,
O	726	728	in
O	729	732	the
O	733	740	partial
O	741	751	dissection
O	752	755	and
O	756	768	conventional
O	769	779	dissection
O	780	786	groups
O	786	787	;
O	788	791	the
O	792	803	differences
O	804	808	were
O	809	812	not
O	813	824	significant
O	824	825	.

B-outcome	826	830	Mean
I-outcome	831	839	duration
I-outcome	840	842	of
I-outcome	843	850	surgery
O	851	852	(
B-iv-cont-mean	852	854	41
I-iv-cont-mean	854	855	.
I-iv-cont-mean	855	856	6
I-iv-cont-mean	857	860	min
O	861	867	versus
B-cv-cont-mean	868	870	60
I-cv-cont-mean	870	871	.
I-cv-cont-mean	871	872	9
I-cv-cont-mean	873	876	min
O	876	877	)
O	877	878	,
B-outcome	879	893	intraoperative
I-outcome	894	899	blood
I-outcome	900	904	loss
O	905	906	(
B-iv-cont-mean	906	908	28
I-iv-cont-mean	908	909	.
I-iv-cont-mean	909	910	0
I-iv-cont-mean	911	913	ml
O	915	921	versus
B-cv-cont-mean	922	924	51
I-cv-cont-mean	924	925	.
I-cv-cont-mean	925	926	3
I-cv-cont-mean	927	929	ml
O	929	930	)
O	930	931	,
B-outcome	932	938	volume
I-outcome	939	941	of
I-outcome	942	951	lymphatic
I-outcome	952	960	drainage
I-outcome	961	963	at
I-outcome	964	965	2
I-outcome	966	971	weeks
I-outcome	972	987	postoperatively
O	988	989	(
B-iv-cont-mean	989	992	488
I-iv-cont-mean	993	995	ml
O	996	1002	versus
B-cv-cont-mean	1003	1006	836
I-cv-cont-mean	1007	1009	ml
O	1009	1010	)
O	1010	1011	,
O	1012	1015	and
B-outcome	1016	1026	persistent
I-outcome	1027	1030	arm
I-outcome	1031	1042	lymphoedema
O	1043	1044	(
B-iv-bin-percent	1044	1045	0
I-iv-bin-percent	1045	1046	.
I-iv-bin-percent	1046	1047	0
I-iv-bin-percent	1047	1048	%
O	1049	1055	versus
B-cv-bin-percent	1056	1058	11
I-cv-bin-percent	1058	1059	.
I-cv-bin-percent	1059	1060	8
I-cv-bin-percent	1060	1061	%
O	1061	1062	)
O	1063	1067	were
O	1068	1081	significantly
O	1082	1091	different
O	1092	1099	between
O	1100	1103	the
O	1104	1111	partial
O	1112	1115	and
O	1116	1128	conventional
O	1129	1139	dissection
O	1140	1146	groups
O	1146	1147	,
O	1148	1160	respectively
O	1160	1161	.

O	1162	1169	Partial
O	1170	1178	axillary
O	1179	1184	lymph
O	1185	1189	node
O	1190	1200	dissection
O	1202	1205	was
O	1206	1216	associated
O	1217	1221	with
O	1222	1229	similar
O	1230	1238	survival
O	1239	1244	rates
O	1245	1246	(
O	1246	1249	but
O	1250	1255	lower
O	1256	1269	postoperative
O	1270	1282	complication
O	1283	1288	rates
O	1288	1289	)
O	1290	1298	compared
O	1299	1303	with
O	1304	1316	conventional
O	1317	1325	axillary
O	1326	1336	dissection
O	1337	1340	and
O	1341	1343	is
O	1344	1355	recommended
O	1356	1358	in
O	1359	1367	patients
O	1368	1372	with
O	1373	1374	N
O	1374	1375	(
O	1375	1376	0
O	1376	1377	)
O	1378	1384	breast
O	1385	1391	cancer
O	1391	1392	.
